NCT05349188View on ClinicalTrials.gov

Feasibility Study of Personalized Trials to Improve Sleep Quality

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

May 16, 2023

Study Completion Date

May 22, 2023

Conditions
Sleep Disturbance
Interventions
DIETARY_SUPPLEMENT

Melatonin 3 mg

Participants will be provided with a smart pill bottle containing a 4-week supply of 3 mg melatonin pills.

DIETARY_SUPPLEMENT

Melatonin 0.5 mg

Participants will be provided with a smart pill bottle containing a 4-week supply of 0.5 mg melatonin pills.

OTHER

Cellulose placebo pill

Participants will be provided with a smart pill bottle containing a 4-week supply of cellulose placebo pills.

Trial Locations (1)

10022

Institute of Health System Science, New York

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
collaborator

National Library of Medicine (NLM)

NIH

collaborator

Columbia University

OTHER

lead

Northwell Health

OTHER

NCT05349188 - Feasibility Study of Personalized Trials to Improve Sleep Quality | Biotech Hunter | Biotech Hunter